Skip to main content
Livermore
Livermore
ZHEN

Creative Planning

SEC CIK
0001540235
Latest filing
Aug 13, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Creative Planning, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
100,290
Value
$8.17M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ARWR by Creative Planning, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026100,290$8.17M<0.1%+12,034+13.6%AddedHolders
Q1 202688,256$5.53M<0.1%+13,835+18.6%AddedHolders
Q4 202574,421$4.94M<0.1%+22,415+43.1%AddedHolders
Q3 202552,006$1.79M<0.1%+6,344+13.9%AddedHolders
Q2 202545,662$721.5K<0.1%+19,194+72.5%AddedHolders
Q1 202526,468$337.2K<0.1%−29,161−52.4%ReducedHolders
Q4 202455,629$1.05M<0.1%+30,220+118.9%AddedHolders
Q3 202425,409$492.2K<0.1%−2,867−10.1%ReducedHolders
Q2 202428,276$734.9K<0.1%+2,420+9.4%AddedHolders
Q1 202425,856$739.5K<0.1%+7,455+40.5%AddedHolders
Q4 202318,401$563.1K<0.1%+1,263+7.4%AddedHolders
Q3 202317,138$460.5K<0.1%−949−5.2%ReducedHolders
Q2 202318,087$645.0K<0.1%+3,712+25.8%AddedHolders
Q1 202314,375$365.1K<0.1%−979−6.4%ReducedHolders
Q4 202215,354$622.8K<0.1%+761+5.2%AddedHolders
Q3 202214,593$482.0K<0.1%+750+5.4%AddedHolders
Q2 202213,843$487.0K<0.1%+1,207+9.6%AddedHolders
Q1 202212,636$581.0K<0.1%+58+0.5%AddedHolders
Q4 202112,578$834.0K<0.1%−745−5.6%ReducedHolders
Q3 202113,323$832.0K<0.1%+750+6.0%AddedHolders
Q2 202112,573$1.04M<0.1%+3,272+35.2%AddedHolders
Q1 20219,301$617.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.